Neos Therapeutics Inc

Compare to Similar Companies

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity	+ Add Column One Year Return PEG Price-to-Book Revenue-to-Enterprise Value EBIT-to-Enterprise Value Total Debt-to-Enterprise Value Total Revenue TTM EBIT TTM Net Income TTM Profit Margin TTM Earnings Growth YOY Return on Assets Return on Invested Capital
Neos Therapeutics Inc	0	-	106%	1.2	-2
Similar Companies

Valuation & Multiples

P/E Ratio	0
PEG	0
Price to Sales	1.15
Price to Book Ratio	-1.15
Enterprise Value to Revenue	-
Enterprise Value to EBIT	-
Enterprise Value to Net Income	0
Total Debt to Enterprise	-
Debt to Equity	-1.97

Revenue Sources

Insider Trades

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

ESG Score

No data

About Neos Therapeutics Inc

CEO: Gerald McLaughlin